APO-go 20mg/2ml solution for injection ampoules Storbritannia - engelsk - MHRA (Medicines & Healthcare Products Regulatory Agency)

apo-go 20mg/2ml solution for injection ampoules

britannia pharmaceuticals ltd - apomorphine hydrochloride - solution for injection - 10mg/1ml

APO-go 50mg/5ml solution for injection ampoules Storbritannia - engelsk - MHRA (Medicines & Healthcare Products Regulatory Agency)

apo-go 50mg/5ml solution for injection ampoules

britannia pharmaceuticals ltd - apomorphine hydrochloride - solution for injection - 10mg/1ml

APO-go PFS 50mg/10ml solution for infusion pre-filled syringes Storbritannia - engelsk - MHRA (Medicines & Healthcare Products Regulatory Agency)

apo-go pfs 50mg/10ml solution for infusion pre-filled syringes

britannia pharmaceuticals ltd - apomorphine hydrochloride - solution for infusion - 5mg/1ml

APOWOK apomorphine hydrochloride hemihydrate 10 mg/mL solution for injection or infusion ampoule Australia - engelsk - Department of Health (Therapeutic Goods Administration)

apowok apomorphine hydrochloride hemihydrate 10 mg/ml solution for injection or infusion ampoule

wockhardt bio pty ltd - apomorphine hydrochloride hemihydrate, quantity: 10 mg/ml - injection, solution - excipient ingredients: sodium metabisulfite; sodium hydroxide; hydrochloric acid; water for injections - apowok solution for injection or infusion is indicated to reduce the number and severity of ?off? phases in patients with parkinson?s disease severely disabled by motor fluctuations refractory to conventional therapy. initiation of therapy with apomorphine should be undertaken in a specialist unit in a hospital setting. conventional therapy should be continued during ?on? phases.

MOVAPO PEN apomorphine hydrochloride hemihydrate 30 mg/3 mL Solution for Injection, Cartridge Australia - engelsk - Department of Health (Therapeutic Goods Administration)

movapo pen apomorphine hydrochloride hemihydrate 30 mg/3 ml solution for injection, cartridge

stada pharmaceuticals australia pty ltd - apomorphine hydrochloride hemihydrate, quantity: 30 mg - injection, solution - excipient ingredients: sodium metabisulfite; hydrochloric acid; water for injections - movapo pen is indicated to reduce the number and severity of 'off' phases in patients with parkinson's disease severely disabled by motor fluctuations refractory to conventional therapy. initiation of therapy with apomorphine should be undertaken in a specialist unit in a hospital setting. conventional therapy should be continued during 'on' phases.

APO-GO® POD SOL.INF 5MG/ML Hellas - gresk - Εθνικός Οργανισμός Φαρμάκων

apo-go® pod sol.inf 5mg/ml

itf hellas ΜΟΝΟΠΡΟΣΩΠΗ ΑΝΩΝΥΜΗ ΕΜΠΟΡΙΚΗ ΚΑΙ ΦΑΡΜΑΚΕΥΤΙΚΗ ΕΤΑΙΡΕΙΑ Δ.Τ. itf hellas s.a. Αρεως 103 & Αγίας Τριάδος 36,, 175 62 17562, Π. Φάληρο 210.9373332 - apomorphine hydrochloride - sol.inf (ΔΙΑΛΥΜΑ ΓΙΑ ΕΓΧΥΣΗ) - 5mg/ml - apomorphine hydrochloride 5mg - apomorphine

APO-go Ampullen 10 mg/ml oplossing voor injectie of infusie Nederland - nederlandsk - CBG-MEB (College ter Beoordeling van Geneesmiddelen)

apo-go ampullen 10 mg/ml oplossing voor injectie of infusie

stada arzneimittel ag stadastrasse 2-18 61118 bad vilbel (duitsland) - apomorfinehydrochloridehemihydraat 10 mg/ml samenstelling overeenkomend met ; apomorfine 8,55 mg/ml - oplossing voor injectie of infusie - natriumhydroxide (e 524) ; natriummetabisulfiet (e 223) ; stikstof (head space) (e 941) ; water voor injectie ; zoutzuur (e 507), - apomorphine

APO-go PEN 10 mg/ml oplossing voor injectie Nederland - nederlandsk - CBG-MEB (College ter Beoordeling van Geneesmiddelen)

apo-go pen 10 mg/ml oplossing voor injectie

stada arzneimittel ag stadastrasse 2-18 61118 bad vilbel (duitsland) - apomorfinehydrochloridehemihydraat 10 mg/ml samenstelling overeenkomend met ; apomorfine 8,5 mg/ml - oplossing voor injectie - natriummetabisulfiet (e 223) ; water voor injectie ; zoutzuur (e 507), - apomorphine

APO-Levetiracetam Oral levetiracetam 100 mg/mL amber glass bottle Australia - engelsk - Department of Health (Therapeutic Goods Administration)

apo-levetiracetam oral levetiracetam 100 mg/ml amber glass bottle

southern cross pharma pty ltd - levetiracetam, quantity: 100 mg/ml - solution - excipient ingredients: propyl hydroxybenzoate; maltitol; purified water; sodium citrate dihydrate; glycerol; ammonium glycyrrhizinate; methyl hydroxybenzoate; acesulfame potassium; citric acid monohydrate; flavour - apo-levitiracetam oral solution is indicated for:,? use in epileptic patients aged 4 years and older, initially as add-on therapy, in the treatment,of partial onset seizures with or without secondary generalisation,,? monotherapy in the treatment of partial onset seizures, with or without secondary,generalisation, in patients from 16 years of age with newly diagnosed epilepsy.,? add-on therapy in the treatment of myoclonic seizures in adults and adolescents from 12,years of age with juvenile myoclonic epilepsy (jme),,? add-on therapy in the treatment of primary generalized tonic clonic (pgtc) seizures in adults and,children from 4 years of age with idiopathic generalized epilepsy (ige).

APOTEL PLUS INJ.SOL (600+20)MG/4ML AMP Hellas - gresk - Εθνικός Οργανισμός Φαρμάκων

apotel plus inj.sol (600+20)mg/4ml amp

uni-pharma ΚΛΕΩΝ ΤΣΕΤΗΣ ΦΑΡΜΑΚΕΥΤΙΚΑ ΕΡΓΑΣΤΗΡΙΑ ΑΒΕΕ 14 ΧΛΜ. ΕΘΝ. ΟΔΟΥ ΑΘΗΝΩΝ-ΛΑΜΙΑΣ, 14564 Κ.ΚΗΦΙΣΙΑ 8072534 8072512 - paracetamol; lidocaine hydrochloride - inj.sol (ΕΝΕΣΙΜΟ ΔΙΑΛΥΜΑ) - (600+20)mg/4ml amp - paracetamol 150mg; lidocaine hydrochloride 5mg - paracetamol, combinations excl. psycholeptics